The invention is based on the discovery that compounds of formula (I) possess unexpectedly high affinity for the A2a adenosine receptor, and can be useful as antagonists thereof for preventing and/or treating numerous diseases, including Parkinson's disease. In one embodiment, the invention features a compound of formula (I).
申请公布号
WO2004092173(A3)
申请公布日期
2004.12.09
申请号
WO2004US11009
申请日期
2004.04.09
申请人
BIOGEN IDEC MA INC.;PENG, HAIRUO;YAO, GANG;VU, CHI;PETTER, RUSSELL C.;KUMARAVEL, GNANASAMBANDAM
发明人
PENG, HAIRUO;YAO, GANG;VU, CHI;PETTER, RUSSELL C.;KUMARAVEL, GNANASAMBANDAM
